Ovintiv Inc. (OVV) PT Lowered to $65 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts OVV Hot Sheet
Price: $62.70 -5.61%
Rating Summary:
25 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
25 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst Devin McDermott lowered the price target on Ovintiv Inc. (NYSE: OVV) to $65.00 (from $68.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Ovintiv Reports Third Quarter 2026 Financial and Operating Results
- Ovintiv Inc. (OVV) PT Raised to $80 at Barclays
- Zimmer Biomet (ZBH) PT Raised to $125 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
